» Articles » PMID: 39770516

The Dynamic Role of Curcumin in Mitigating Human Illnesses: Recent Advances in Therapeutic Applications

Overview
Publisher MDPI
Specialty Chemistry
Date 2025 Jan 8
PMID 39770516
Authors
Affiliations
Soon will be listed here.
Abstract

Herbal medicine, particularly in developing regions, remains highly popular due to its cost-effectiveness, accessibility, and minimal risk of adverse effects. L., commonly known as turmeric, exemplifies such herbal remedies with its extensive history of culinary and medicinal applications across Asia for thousands of years. Traditionally utilized as a dye, flavoring, and in cultural rituals, turmeric has also been employed to treat a spectrum of medical conditions, including inflammatory, bacterial, and fungal infections, jaundice, tumors, and ulcers. Building on this longstanding use, contemporary biochemical and clinical research has identified curcumin-the primary active compound in turmeric-as possessing significant therapeutic potential. This review hypothesizes that curcumin's antioxidant properties are pivotal in preventing and treating chronic inflammatory diseases, which are often precursors to more severe conditions, such as cancer, and neurological disorders, like Parkinson's and Alzheimer's disease. Additionally, while curcumin demonstrates a favorable safety profile, its anticoagulant effects warrant cautious application. This article synthesizes recent studies to elucidate the molecular mechanisms underlying curcumin's actions and evaluates its therapeutic efficacy in various human illnesses, including cancer, inflammatory bowel disease, osteoarthritis, atherosclerosis, peptic ulcers, COVID-19, psoriasis, vitiligo, and depression. By integrating diverse research findings, this review aims to provide a comprehensive perspective on curcumin's role in modern medicine and its potential as a multifaceted therapeutic agent.

References
1.
Mansouri K, Rasoulpoor S, Daneshkhah A, Abolfathi S, Salari N, Mohammadi M . Clinical effects of curcumin in enhancing cancer therapy: A systematic review. BMC Cancer. 2020; 20(1):791. PMC: 7446227. DOI: 10.1186/s12885-020-07256-8. View

2.
Das S, Gopal P, Thomas J, Mohan M, Thomas S, Maliakel B . Influence of CurQfen-curcumin on cognitive impairment: a randomized, double-blinded, placebo-controlled, 3-arm, 3-sequence comparative study. Front Dement. 2024; 2:1222708. PMC: 11285547. DOI: 10.3389/frdem.2023.1222708. View

3.
Aggarwal B, Gupta S, Sung B . Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers. Br J Pharmacol. 2013; 169(8):1672-92. PMC: 3753829. DOI: 10.1111/bph.12131. View

4.
Momtazi-Borojeni A, Abdollahi E, Nikfar B, Chaichian S, Ekhlasi-Hundrieser M . Curcumin as a potential modulator of M1 and M2 macrophages: new insights in atherosclerosis therapy. Heart Fail Rev. 2019; 24(3):399-409. DOI: 10.1007/s10741-018-09764-z. View

5.
Rashidzadeh H, Salimi M, Sadighian S, Rostamizadeh K, Ramazani A . In vivo Antiplasmodial Activity of Curcumin-Loaded Nanostructured Lipid Carriers. Curr Drug Deliv. 2019; 16(10):923-930. DOI: 10.2174/1567201816666191029121036. View